AS

Anjana Saxena

Active Director Director DIN 10644364
DIN 10644364 First appointment May 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value •••• Premium profile

About Anjana Saxena

Data last updated:

Anjana Saxena is a Director at Oystershell Life Sciences Private Limited (since 2024). The company operates in Pharma. Oystershell Life Sciences Private Limited reported revenue of ₹1.11 Cr (FY 2024).

DIN 10644364
Primary Designation Director
Industry Pharma
First Appointment 27 May 2024
Oldest Company Age 9 yrs
Largest company Oystershell Life Sciences Private Limited · ₹1.11 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 May 20242017₹1.11 Cr (FY 2024)Active

Board colleagues of Anjana Saxena

Directorship timeline

Open interactive timeline →
Oystershell Life Sciences Private Limited
Premium access

Shareholding and investment profile for Anjana Saxena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjana Saxena

Anjana Saxena currently holds 1 directorship: Oystershell Life Sciences Private Limited (Director, since 27 May 2024, revenue ₹1.11 Cr (FY 2024)).

Anjana Saxena was first appointed on 27 May 2024 as Director at Oystershell Life Sciences Private Limited.

The current boards of Anjana Saxena's companies include Rahul Thakur (Oystershell Life Sciences Private Limited), Sohan (Oystershell Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available